Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma
Mantle cell lymphoma is a relatively rare type of mature B-cell non-Hodgkin’s lymphoma with an incidence of approximately 8 cases per million persons per year. In patients with mantle cell lymphoma, there are rare case reports of the potentially life-threatening consequences of splenic rupture and r...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2019/2429098 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562865869946880 |
|---|---|
| author | Jared Williams Shingi Chiruka |
| author_facet | Jared Williams Shingi Chiruka |
| author_sort | Jared Williams |
| collection | DOAJ |
| description | Mantle cell lymphoma is a relatively rare type of mature B-cell non-Hodgkin’s lymphoma with an incidence of approximately 8 cases per million persons per year. In patients with mantle cell lymphoma, there are rare case reports of the potentially life-threatening consequences of splenic rupture and rituximab-induced acute thrombocytopenia (RIAT) occurring separately, but there are no reports of these occurring in the same patient. Whilst rare, they are important to be aware of as early detection may prevent fatal outcomes. |
| format | Article |
| id | doaj-art-38dabe6e80ae445bb780eeabf6fdd894 |
| institution | Kabale University |
| issn | 2090-6560 2090-6579 |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Hematology |
| spelling | doaj-art-38dabe6e80ae445bb780eeabf6fdd8942025-02-03T01:21:31ZengWileyCase Reports in Hematology2090-65602090-65792019-01-01201910.1155/2019/24290982429098Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell LymphomaJared Williams0Shingi Chiruka1Department of Haematology, Dunedin Hospital, 201 Great King Street, Dunedin 9016, New ZealandDepartment of Haematology, Dunedin Hospital, 201 Great King Street, Dunedin 9016, New ZealandMantle cell lymphoma is a relatively rare type of mature B-cell non-Hodgkin’s lymphoma with an incidence of approximately 8 cases per million persons per year. In patients with mantle cell lymphoma, there are rare case reports of the potentially life-threatening consequences of splenic rupture and rituximab-induced acute thrombocytopenia (RIAT) occurring separately, but there are no reports of these occurring in the same patient. Whilst rare, they are important to be aware of as early detection may prevent fatal outcomes.http://dx.doi.org/10.1155/2019/2429098 |
| spellingShingle | Jared Williams Shingi Chiruka Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma Case Reports in Hematology |
| title | Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma |
| title_full | Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma |
| title_fullStr | Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma |
| title_full_unstemmed | Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma |
| title_short | Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma |
| title_sort | spontaneous splenic rupture and rituximab induced acute thrombocytopenia in a patient with high risk mantle cell lymphoma |
| url | http://dx.doi.org/10.1155/2019/2429098 |
| work_keys_str_mv | AT jaredwilliams spontaneoussplenicruptureandrituximabinducedacutethrombocytopeniainapatientwithhighriskmantlecelllymphoma AT shingichiruka spontaneoussplenicruptureandrituximabinducedacutethrombocytopeniainapatientwithhighriskmantlecelllymphoma |